Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-17
DOI
10.1038/s41598-022-04892-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Muscle-Specific Promoters for Gene Therapy
- (2021) Victoria V. Skopenkova et al. Acta Naturae
- Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans
- (2020) Gwladys Gernoux et al. MOLECULAR THERAPY
- Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
- (2020) Giuseppe Ronzitti et al. Frontiers in Immunology
- In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin
- (2020) Kirill A. Danilov et al. EXPERIMENTAL CELL RESEARCH
- Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy
- (2019) John C. W. Hildyard et al. PLoS One
- CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
- (2019) Tatiana V. Egorova et al. Disease Models & Mechanisms
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
- (2019) Yafeng Song et al. NATURE MEDICINE
- Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice
- (2018) Cinzia Pisani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
- (2018) Tahnee L. Kennedy et al. Molecular Therapy-Methods & Clinical Development
- Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy
- (2017) Mikako Ito et al. HUMAN GENE THERAPY
- Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI
- (2017) Rita Ferla et al. Molecular Therapy-Methods & Clinical Development
- A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy
- (2017) Chady H. Hakim et al. Molecular Therapy-Methods & Clinical Development
- Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system
- (2016) Pierre-Olivier Buclez et al. Molecular Therapy-Methods & Clinical Development
- Duchenne Muscular Dystrophy Gene Therapy in the Canine Model
- (2015) Dongsheng Duan Human Gene Therapy Clinical Development
- Assessing Functional Performance in the Mdx Mouse Model
- (2014) Annemieke Aartsma-Rus et al. Jove-Journal of Visualized Experiments
- Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. MUSCLE & NERVE
- Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
- (2012) Christine Aurnhammer et al. Human Gene Therapy Methods
- Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α1-Antitrypsin: Interim Results
- (2011) Terence R. Flotte et al. HUMAN GENE THERAPY
- Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse
- (2011) Jonathon M. Tinsley et al. PLoS One
- Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
- (2011) Catherine Moorwood et al. PLoS One
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
- (2010) A. R. Amenta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Persistent Expression of FLAG-tagged Micro dystrophin in Nonhuman Primates Following Intramuscular and Vascular Delivery
- (2009) Louise R Rodino-Klapac et al. MOLECULAR THERAPY
- Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
- (2009) Kevin J. Sonnemann et al. PLOS MEDICINE
- CellProfiler Analyst: data exploration and analysis software for complex image-based screens
- (2008) Thouis R Jones et al. BMC BIOINFORMATICS
- Construction and analysis of compact muscle-specific promoters for AAV vectors
- (2008) B Wang et al. GENE THERAPY
- Microutrophin Delivery Through rAAV6 Increases Lifespan and Improves Muscle Function in Dystrophic Dystrophin/Utrophin-deficient Mice
- (2008) Guy L Odom et al. MOLECULAR THERAPY
- Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer
- (2008) Helen Foster et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search